Equities
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)428.40
  • Today's Change-1.00 / -0.23%
  • Shares traded156.98k
  • 1 Year change+6.38%
  • Beta0.5694
Data delayed at least 15 minutes, as of Sep 15 2026 15:41 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2025202520242023
REVENUE AND GROSS PROFIT
Total revenue4,1583,8342,403
OPERATING EXPENSES
Cost of revenue total1,9162,0241,098
Selling, general and admin. expenses, total768660418
Depreciation/amortization23018666
Unusual expense(income)8815865
Other operating expenses, total(17)(28)(11)
Total operating expense3,3413,3331,869
Operating income817501534
Other, net(12)(12)11
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes743417525
Provision for income taxes160111117
Net income after taxes584306408
Minority interest00(2.01)
Net income before extra. Items584306406
Total extraordinary items------
Net income584306406
Inc.avail. to common excl. extra. Items584306406
Inc.avail. to common incl. extra. Items584306406
EPS RECONCILIATION
Basic/primary weighted average shares466458277
Basic/primary eps excl. extra items1.250.671.47
Basic/primary eps incl. extra items1.250.671.47
Dilution adjustment------
Diluted weighted average shares468460278
Diluted eps excl. extra items1.250.671.46
Diluted eps incl. extra items1.250.671.46
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.870.830.83
Gross dividend - common stock4073870
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental687621
SUPPLEMENTAL INCOME
Depreciation, supplemental257239162
Total special items8821165
NORMALISED INCOME
Normalized income before taxes831628590
Effect of special items on income taxes196515
Income tax excluding impact of special items179176131
Normalized income after tax653452459
Normalized income avail. to common653452457
Basic normalized EPS1.400.991.65
Diluted normalized EPS1.400.981.64
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.